BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8129383)

  • 1. [Neoadjuvant chemotherapy for far-advanced gastric carcinoma].
    Mai M; Takahashi Y; Fujimoto T; Omote K
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):431-9. PubMed ID: 8129383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on neoadjuvant chemotherapy of Borrmann 4 type carcinoma of stomach and its clinical significance].
    Mai M; Ogino T; Ueda H; Ooi A; Takahashi Y; Sawaguchi K; Suga T; Ohta T; Asai T; Itoh T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):586-97. PubMed ID: 2351851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of papillary adenocarcinoma of the stomach with liver metastases and carcinomatous peritonitis treated effectively by methotrexate/5-fluorouracil sequential chemotherapy].
    Iwamoto S; Kimoto M; Mure T; Imai H; Fujimori Y; Onuma E; Iki K; Yoshida K; Tadaoka Y; Kubozoe T; Takeo T; Murakami T; Kawasaki S; Yamamoto Y; Tsunoda T
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):2005-9. PubMed ID: 9350250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy for advanced gastric cancer with para-aortic lymph node metastasis].
    Uehara S; Murabayashi K; Kusta T; Takahashi K; Ogawa T; Onishi H; Saegusa S; Noda N; Okanami Y; Nakamura I
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1413-8. PubMed ID: 11681249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
    Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
    Schuhmacher CP; Fink U; Becker K; Busch R; Dittler HJ; Mueller J; Siewert JR
    Cancer; 2001 Mar; 91(5):918-27. PubMed ID: 11251943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A patient with advanced gastric cancer surviving for more than 5 years after neoadjuvant chemotherapy and curative resection].
    Hirota M; Kimura J; Eguchi T; Kato K; Kobayashi H; Kanazumi N; Suzuki Y; Ishii M
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):125-9. PubMed ID: 11816468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant chemotherapy for elderly advanced gastric cancer: a case report of MTX/5-FU sequential therapy followed by radical gastrectomy].
    Saitoh A; Fukuhara T; Kikuchi H; Tsushima K; Tanaka M; Kudoh H; Narita N; Sakata Y
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2039-43. PubMed ID: 8085855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of synergism and clinical results of sequential methotrexate and 5-fluorouracil in the treatment of gastric cancer].
    Konishi T; Hirata T; Miyama T; Hiraishi M; Mafune K; Yoshida J; Mori K; Nishina H; Idezuki Y
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):946-53. PubMed ID: 1626950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of stage IV advanced gastric cancer responding to TS-1/CDDP neoadjuvant chemotherapy which leads to a pathological complete response].
    Hiraoka K; Mizutani S; Oyama T; Uchikoshi F; Yoshidome K; Tori M; Ueshima S; Yamagami Y; Takahashi H; Nakahara M; Tsujimoto M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):93-5. PubMed ID: 17220679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.